Stay updated with breaking news from Tim Demuth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
04.04.2023 - EQS-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023 04.04.2023 / 22:01 CET/CEST The issuer is solely responsible ...
Julia Neugebauer: Ladies and gentlemen, good afternoon and good morning.
Operator: Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Third Quarter 2022 Financial Results Conference Call of MorphoSys.
EQS-News: MorphoSys AG / Key word(s): MiscellaneousMorphoSys Presents Updated Tafasitamab Results in Newly Diagnosed DLBCL Patients from Final firstMIND Analysis at ASH 2022 10.12.2022 / 23:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Media Release PLANEGG/MUNICH, Germa...
EQS-News: MorphoSys AG / Key word(s): MiscellaneousMorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022 11.12.2022 / 23:31 CET/CESTThe issuer is solely responsible for the content of this announcement.Media Release ...